Ma'an Muhsin, M.D. is a highly experienced medical professional specializing in oncology and immuno-oncology, currently serving as the Global Head of GI Oncology at Revolution Medicines since August 2025. In addition to this role, Ma'an holds a position as a Medical Consultant in Oncology at JANUS MM BioConsulting, providing expertise in clinical development strategy and trial design. Previous leadership positions include Chief Medical Officer and President of the Oncology Division at Kriya Therapeutics, where Ma'an introduced an innovative "Immunogene Therapy" for cancer treatment. Throughout a robust career that spans multiple companies, including Arrowhead Pharmaceuticals and Nektar Therapeutics, Ma'an has demonstrated a profound commitment to advancing cancer therapies through strategic clinical development and medical oversight. Educational qualifications include a Doctor of Medicine (M.D.) degree from a school of medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices